Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1061 of 1,261

  1. US 7364726

    Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

    The Regents of the University of California · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted

  2. US 7365165

    IL-1 antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted

  3. EP 1913959

    Radioaktive Metallkomplexe enthaltend eine Tridentat-Komplex-Sequenz

    CIS BIO INT [FR] · Granted Apr 23, 2008 · Expires Apr 18, 2028

    granted

  4. US 7361665

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  5. US 7361350

    Use of an IL-1 antagonist for treating arthritis

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  6. US 7361332

    Treating tumors using implants comprising combinations of allogeneic cells

    The Regents of the University of California · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  7. US 7361476

    Methionyl tRNA synthetase polynucleotides

    Replidyne, Inc. · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  8. US 7361355

    Mutant forms of cholera holotoxin as an adjuvant

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  9. US 7361756

    Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  10. US 7361680

    Indole compounds useful for the treatment of cancer

    The Regents of the University of California · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  11. US 7361752

    RNAi modulation of MLL-AF4 and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  12. US 7361671

    Substituted heteroarylalkanoic acids

    The Institute for Pharmaceutical Discovery, LLC · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  13. US 7361646

    Methods for treating gastroesophageal reflux disease

    Corcept Therapeutics Incorporated · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  14. US 7361356

    Self-assembling recombinant papillomavirus capsid proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  15. US 7361664

    Vitamin D receptor antagonists and related compositions and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  16. US 7361504

    Culturing Anaplasma

    Regents of the University of Minnesota · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  17. US 7358377

    Schweinfurthin analogues

    The United States of America · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  18. US 7358364

    Substituted carboxylic acids

    The Institute for Pharmaceutical Discovery, LLC · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  19. US 7358273

    Inhibitors of caspases

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  20. US 7358390

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  21. US 7358360

    Risedronate sodium having a very low content of iron

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  22. US 7358260

    Quinuclidine derivatives and medicinal compositions containing the same

    Laboratories Almirall, S.A. · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  23. US 7358222

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

  24. US 7358258

    Prodrugs of an ERK protein kinase inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Apr 15, 2008 · Expires Apr 10, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.